In conclusion, our findings suggest that SOCS2 may be capable of a potential biomarker for predicting the prognosis of radiotherapy as well as a potential new therapeutic target for enhancing radiosensitivity of HCC. Here, SOCS2 is linked to hepatocellular carcinoma.